Details of Drug

Drug General Information (ID: D1819)
Drug Name	Indium In-111 pentetreotide
Drug Type	Small molecule
Drug Synonymous	Indium In-111 pentetreotide\|Indium In 111 Pentreotide\|Indium (111in) pentetreotide\|DB11835 Click to Show/Hide
Therapeutic Class	Diagnostic Radiopharmaceuticals
Structure
Structure	3D Structure		2D Structure
Formula	C62H80InN12O19S2-
InChI	InChI=1S/C62H84N12O19S2.In/c1-35(76)47(32-75)69-59(88)49-34-95-94-33-48(70-55(84)44(25-37-13-5-3-6-14-37)65-50(78)29-74(31-52(81)82)24-23-73(30-51(79)80)22-20-41(61(90)91)62(92)93)58(87)67-45(26-38-15-7-4-8-16-38)56(85)68-46(27-39-28-64-42-18-10-9-17-40(39)42)57(86)66-43(19-11-12-21-63)54(83)72-53(36(2)77)60(89)71-49;/h3-10,13-18,28,35-36,41,43-49,53,64,75-77H,11-12,19-27,29-34,63H2,1-2H3,(H,65,78)(H,66,86)(H,67,87)(H,68,85)(H,69,88)(H,70,84)(H,71,89)(H,72,83)(H,79,80)(H,81,82)(H,90,91)(H,92,93);/q;+3/p-4/i;1-4
InChIKey	ZKZPXKKVDJOAIS-JWFOFJTQSA-J
Canonical SMILES	CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=N1)[O-])CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N=C(CN(CCN(CCC(C(=O)O)C(=O)O)CC(=O)[O-])CC(=O)[O-])[O-])C(=O)NC(CO)C(C)O)O.[111In+3]
External Link
External Link	Pubchem ID	131704321

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM003 Affected organization distribution BM014 Interference of cell/tissue uptake
Relation Graph

Full list of drugs interacting with Indium In-111 pentetreotide
Affected organization distribution
	Interference of cell/tissue uptake					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0891		Lanreotide	C54H69N11O10S2	71349	Moderate		Inter Info	[1], [2], [3]
D1163		Octreotide	C49H66N10O10S2	448601	Moderate		Inter Info	[1], [2], [3]

References
1	Product Information. Sandostatin (octreotide). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
2	Product Information. Somatuline Depot (lanreotide). Ipsen Inc, Milford, MA.
3	Product Information. Octreoscan (indium pentetreotide In-111). Mallinckrodt Medical Inc, St. Louis, MO.